Author: Dib-Hajj S.D. Hinson A.W. Black J.A. Waxman S.G. Rocholl A. Heusser E. Kirsten T. Oehm J. Richter H.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.317, Iss.2, 1996-12, pp. : 4773-4783
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Targets Involved in Cardioprotection by the Non-Anesthetic Noble Gas Helium
Current Drug Targets, Vol. 16, Iss. 8, 2015-01 ,pp. :
Current Management of Mantle Cell Lymphoma
By Weigert Oliver Unterhalt Michael Hiddemann Wolfgang Dreyling Martin
Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. :
Patients with relapsed or refractory mantle cell lymphoma may receive benefit from bortezomib
Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. :
Novel therapeutic targets in mantle cell lymphoma
By Martin Peter Leonard John P
Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. :